e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Non-antibiotic effects of macrolides in lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Macrolides in the prevention of COPD exacerbations
J. Wedzicha (London, United Kingdom)
Source:
Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
Session:
Non-antibiotic effects of macrolides in lung disease
Session type:
Symposium
Number:
3067
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Wedzicha (London, United Kingdom). Macrolides in the prevention of COPD exacerbations. Annual Congress 2012 - Non-antibiotic effects of macrolides in lung disease
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Corticosteroids and exacerbations of COPD
Source: Annual Congress 2007 - Corticosteroids and respiratory failure
Year: 2007
Recommendations on long-term antibiotics and mucolytics for prevention of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017
Antibiotics in exacerbations of asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014
Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017
Prevention of exacerbations of COPD with pharmacotherapy
Source: Eur Respir Rev 2009; 19: 119-126
Year: 2010
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Pharmacologic treatment of exacerbations of COPD
Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Year: 2016
Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
Causes and management of exacerbations of COPD
Source: ISSN=ISSN 1810-6838, ISBN=, page=250
Year: 2007
Antibiotics in COPD exacerbations: practice and evidence
Source: Breathe 2009; 5: 299-301
Year: 2009
An evaluation of exacerbations in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 89s
Year: 2004
Statins and outcome of COPD patients after hospitalization for COPD exacerbations
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
Recommendations for pharmacological treatment of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017
Exacerbations of COPD and treatment
Source: International Congress 2018 – PG1 Asthma and chronic obstructive pulmonary disease
Year: 2018
The prevention of AECOPD
Source: International Congress 2016 – The management of acute exacerbations of COPD
Year: 2016
Evaluation of COPD exacerbations using the EXACT-U
Source: Annual Congress 2010 - COPD exacerbation
Year: 2010
COPD exacerbations: impact and prevention
Source: Breathe 2013; 9: 434-440
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept